Literature DB >> 14742316

Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis).

Jordane Biarc1, Isabelle S Nguyen, Annelise Pini, Francine Gossé, Sophie Richert, Danielle Thiersé, Alain Van Dorsselaer, Emmanuelle Leize-Wagner, Francis Raul, Jean-Paul Klein, Marie Schöller-Guinard.   

Abstract

Several studies reported linkage between bacterial infections and carcinogenesis. Streptococcus bovis was traditionally considered as a lower grade pathogen frequently involved in bacteremia and endocarditis. This bacterium became important in human health as it was shown that 25-80% of patients who presented a S.bovis bacteremia had also a colorectal tumor. Moreover, in previous experiments, we demonstrated that S.bovis or S.bovis wall extracted antigens (WEA) were able to promote carcinogenesis in rats. The aim of the present study was: (i) to identify the S.bovis proteins responsible for in vitro pro-inflammatory properties; (ii) to purify them; (iii) to examine their ability to stimulate in vitro IL-8 and COX-2 expression by human colon cancer cells; and (iv) to assess in vivo their pro-carcinogenic potential in a rat model of colon carcinogenesis. The purified S300 fraction, as determined by proteomic analysis, contained 72 protein spots in two-dimensional gel electrophoresis representing 12 different proteins able to trigger human epithelial colonic Caco-2 cells and rat colonic mucosa to release CXC chemokines (human IL-8 or rat CINC/GRO) and prostaglandins E2, correlated with an in vitro over-expression of COX-2. Moreover, these proteins were highly effective in the promotion of pre-neoplastic lesions in azoxymethane-treated rats. In the presence of these proteins, Caco-2 cells exhibited enhanced phosphorylation of the three classes of MAP kinases. Our results show a relationship between the pro-inflammatory potential of S.bovis proteins and their pro-carcinogenic properties, confirming the linkage between inflammation and colon carcinogenesis. These data support the hypothesis that colonic bacteria can contribute to cancer development particularly in chronic infection/inflammation diseases where bacterial components may interfere with cell function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742316     DOI: 10.1093/carcin/bgh091

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  73 in total

1.  The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U.

Authors:  Lorraine A Draper; John R Tagg; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Streptococcus bovis endophthalmitis: a unique presentation of colon cancer.

Authors:  Wissam Bleibel; Karl D'Silva; Ali Elhorr; Samer Bleibel; Upandra Dhanjal
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

Review 3.  Salivary biomarkers for clinical applications.

Authors:  Lei Zhang; Hua Xiao; David T Wong
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  [High-throughput sequencing for analysis of structural change of intestinal microbiota in patients with colorectal adenoma].

Authors:  Ying-Ying Lu; Yue Zeng; Guo-Yong Hu; Xing-Peng Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

Review 5.  Immune reaction and colorectal cancer: friends or foes?

Authors:  Vincenzo Formica; Vittore Cereda; Antonella Nardecchia; Manfredi Tesauro; Mario Roselli
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 6.  Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen.

Authors:  Kelly M Robinson; Julie C Dunning Hotopp
Journal:  Cancer Lett       Date:  2014-06-21       Impact factor: 8.679

Review 7.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

8.  Proteomics strategy for identifying candidate bioactive proteins in complex mixtures: application to the platelet releasate.

Authors:  Roisin O'Connor; Lorna M Cryan; Kieran Wynne; Andreas de Stefani; Desmond Fitzgerald; Colm O'Brien; Gerard Cagney
Journal:  J Biomed Biotechnol       Date:  2010-03-24

9.  Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Layla K Mahdi; Tarik Al-jeboori; Fatimah Abubaker
Journal:  BMC Cancer       Date:  2009-11-19       Impact factor: 4.430

10.  A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection.

Authors:  Farhan Rashid; Naseem Waraich; Imran Bhatti; Shopan Saha; Raheela N Khan; Javed Ahmed; Paul C Leeder; Mike Larvin; Syed Y Iftikhar
Journal:  World J Surg Oncol       Date:  2010-01-06       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.